Baxter to Host First-Quarter 2023 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX) has announced a conference call scheduled for April 27, 2023, at 7:30 a.m. Central Time to discuss its first-quarter 2023 financial results. Participants can pre-register for the call via the provided link or access it through Baxter's website. The call will be recorded and copyrighted by Baxter, with restrictions on rebroadcasting without permission. Baxter is recognized for its extensive portfolio in diagnostic, critical care, kidney care, nutrition, and surgical products, emphasizing its commitment to innovation and patient care over the past 90 years.
- None.
- None.
This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005540/en/
Media Contact
media@baxter.com
Investor Contact
Source:
FAQ
What is the date for Baxter's Q1 2023 earnings call?
What time will Baxter's earnings conference call start?
How can I participate in Baxter's Q1 conference call?
Where can I find the recorded version of Baxter's earnings call?